The IVF for Military Families Act inserts a new, standalone entitlement into Title 10 requiring the Department of Defense to ensure fertility-related care is covered under TRICARE Prime and TRICARE Select for active‑duty service members and their dependents. The statutory definition bundles diagnosis, a broad set of assisted-reproduction procedures (including IVF), gamete preservation, and coordination services into the covered benefit.
For practitioners and compliance officers, the bill matters because it converts reproductive services that many TRICARE beneficiaries now obtain out of pocket or through piecemeal arrangements into a defined TRICARE benefit, creates new contracting and coordination duties for the Military Health System and TRICARE contractors, and sets clinical limits (notably a cap on oocyte retrievals) that will shape coverage decisions and provider reimbursement policy once implemented.
At a Glance
What It Does
Adds section 1074p to Title 10 to require TRICARE Prime and Select coverage of fertility-related care for active-duty members and their dependents, and creates a separate DoD program to coordinate fertility care and train community providers. It also amends section 1079(a) to reference the new coverage requirements.
Who It Affects
Directly affects active-duty service members and their dependents eligible for TRICARE Prime or Select, Military Health System medical treatment facilities, TRICARE contractors, and civilian fertility clinics that treat TRICARE patients. The Secretary of Defense gains implementation authority and discretion to define certain covered services.
Why It Matters
This bill makes the federal military health program an explicit payer for a broad suite of assisted-reproduction services, shaping clinical access and likely driving contractual and operational changes across DoD and TRICARE networks. It also sets a concrete clinical constraint — a retrieval cap — that will affect treatment planning and benefit design.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB1231 directs the Secretary of Defense to ensure fertility-related care is a covered benefit under TRICARE Prime and TRICARE Select for members of the uniformed services on active duty and their dependents. Rather than leaving fertility services to ad hoc arrangements, the bill creates a statutory entitlement: diagnosis of infertility and a list of specific treatments become billable under TRICARE when medically appropriate.
The statute treats in vitro fertilization as a central covered service but places a numeric limit on one component of the process: the law allows no more than three completed oocyte retrievals per individual while permitting unlimited embryo transfers consistent with American Society for Reproductive Medicine (ASRM) guidance. The text also enumerates other covered elements — sperm and egg retrieval, cryopreservation of gametes and embryos, several forms of artificial insemination, transfer of reproductive genetic material, fertility-related medications, and care coordination — and gives the Secretary authority to add additional reproductive services as appropriate.Beyond benefit language, the bill establishes a DoD program to coordinate fertility-related care and requires the department to provide training and support to community providers about the unique needs of military families.
A conforming amendment instructs existing statutory reimbursement provisions to follow the new coverage rule. The law’s operative date is explicit: the coverage obligation applies to services furnished on or after October 1, 2027, which creates a defined implementation window for DoD, TRICARE contractors, and clinical partners to update networks, prior-authorization rules, and billing flows.
The Five Things You Need to Know
The bill adds a new Title 10 section (1074p) requiring TRICARE Prime and TRICARE Select to cover fertility-related care for active‑duty members and their dependents.
For IVF specifically, the statute limits coverage to not more than three completed oocyte retrieval procedures per individual.
The law allows unlimited embryo transfers, but conditions them on compliance with American Society for Reproductive Medicine guidelines.
The covered services list explicitly includes gamete and embryo preservation (cryopreservation), sperm/egg retrieval, artificial insemination (intravaginal, intracervical, intrauterine), and fertility‑related medications.
The bill creates a DoD program (new section 1110c) to coordinate fertility care and to provide training and support to community providers; coverage takes effect for services on or after October 1, 2027.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title — 'IVF for Military Families Act'
This is the formal short title of the measure. It frames the bill’s purpose for legislative and implementation documents, but carries no substantive legal obligations.
TRICARE Prime and Select must cover fertility-related care for active-duty members and dependents
Subsection (a) imposes an affirmative obligation on the Secretary of Defense to ‘ensure’ coverage of fertility-related care under TRICARE Prime and Select for a member of the uniformed services on active duty and for dependents of such members. That choice of words signals a programmatic duty — DoD must incorporate fertility care into TRICARE benefit design, network arrangements, and claims processing for eligible beneficiaries.
Caps on oocyte retrievals; embryo transfers aligned with ASRM
Subsection (b) sets two clinical coverage rules: a statutory ceiling of three completed oocyte retrievals and no limit on embryo transfers so long as transfers follow ASRM guidance. Practically, the retrieval cap fixes one access parameter while exempting transfer frequency from a similar numeric cap, shifting pressure onto embryology outcomes and clinical decision-making about embryo creation and storage.
Defines 'infertility' and enumerates covered fertility treatments
Subsection (c) supplies a working definition of infertility (explicitly referencing ASRM guidance among the criteria) and a non‑exhaustive list of covered services: IVF and other procedures involving gametes/embryos, sperm and egg retrieval, preservation of oocytes/embryos/sperm, multiple types of artificial insemination, transfer of reproductive genetic material, medications, and fertility treatment coordination. The Secretary retains authority to identify additional services as appropriate, which creates administrative discretion during benefit implementation.
Program to coordinate fertility-related care and train community providers
The bill adds a separate statutory program requiring DoD to coordinate fertility-related care and to provide training/support to community (civilian) providers about military-specific needs. This provision acknowledges DoD’s limited internal capacity for specialized reproductive services and creates a statutory basis for education, referral networks, and potentially bilateral agreements with civilian clinics.
Conforming change to section 1079(a) and application date
The measure amends 10 U.S.C. §1079(a) to instruct that fertility-related care be provided consistent with the new section 1074p. It also states that the amendments apply to services provided on or after October 1, 2027, establishing a clear implementation deadline that will require DoD and TRICARE contractors to redesign coverage policies, prior-authorization protocols, and provider agreements before that date.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Active-duty service members of reproductive age who need assisted-reproduction services — they gain an explicit TRICARE-covered pathway for diagnosis, IVF, preservation, and related procedures that previously were often uncovered or paid out-of-pocket.
- Dependents of active-duty members, including spouses and dependents who require fertility treatment — the statutory language brings those family members into TRICARE’s coverage frame for these services.
- Service members seeking fertility preservation (e.g., before deployment or medical treatment) — the bill explicitly covers cryopreservation of oocytes, embryos, and sperm, which protects future reproductive options.
- Civilian fertility clinics and reproductive endocrinologists — bringing these services into TRICARE’s covered benefits creates a potential new payer relationship and patient stream, provided reimbursement and administrative processes support participation.
- Military readiness and retention stakeholders — by addressing a common family-building need through benefit design, the policy supports personnel retention and may reduce career disruptions related to infertility treatment access.
Who Bears the Cost
- Department of Defense/Defense Health Program budgets — expanding TRICARE benefits increases the program’s covered-service load and will require appropriation or internal reprioritization to fund treatments and provider payments.
- TRICARE contractors and claims administrators — they must update coverage rules, prior-authorization criteria, billing systems, and provider networks to incorporate a complex set of reproductive services.
- Military Treatment Facilities (MTFs) and military clinicians — where DoD elects to provide services on-base, facilities will face staffing, training, and capacity demands to offer or coordinate specialized fertility care.
- Civilian clinics that serve TRICARE beneficiaries — while they may gain patients, clinics will also face administrative overhead from TRICARE reimbursement rates, requirements, and possible audit/compliance obligations.
- Taxpayers — as the federal payer for military health benefits, the cost of expanded fertility coverage will ultimately be borne by federal budgets unless offset by other savings or appropriations.
Key Issues
The Core Tension
The central tension in SB1231 is between guaranteeing broad clinical access to assisted‑reproduction services for military families and constraining costs and program complexity through statutory limits and administrative discretion; the bill grants meaningful coverage while embedding a retrieval cap and leaving major implementation choices (scope additions, reimbursement, network rules) to DoD — a structure that solves some access problems but shifts difficult clinical and fiscal trade-offs to the administration.
The bill leaves several consequential implementation questions to the Secretary of Defense and program administrators. First, the numeric cap of three completed oocyte retrievals is an unusual statutory limit: it fixes one clinical parameter while leaving embryo transfers unconstrained.
That split creates a practical issue for patients with low ovarian response — three retrievals may yield few embryos, and unlimited transfers cannot help if embryos do not exist. Determining medical necessity, exceptions, and appeals for patients who fail to produce embryos within three retrievals will fall to regulators and claims staff.
Second, the statute repeatedly references ASRM guidance (for defining infertility and governing embryo transfers) and gives the Secretary authority to add 'other' services. Relying on external clinical guidance helps keep clinical standards current but also introduces dependence on a private professional body’s evolving recommendations.
Administratively, DoD will have to translate ASRM standards into TRICARE policy, prior-authorization checklists, and provider training. Third, the coordination program and the training mandate signal DoD’s expectation that civilian clinics will play a major role, but the bill is silent on reimbursement levels, network adequacy standards, prior-authorization timelines, and protections for patients who must travel to access care.
Those operational details will determine whether coverage is meaningful in practice or becomes a paper entitlement with poor access.
Finally, the bill’s coverage gate — 'member on active duty (or a dependent of such a member)' — is precise but narrow. The measure does not extend the explicit entitlement to retirees, veterans, or members of the Reserve/Guard who are not on active duty, creating a potential policy gap for people with military service connections.
The October 1, 2027 effective date creates an implementation window but also a cliff during which current patients may still lack coverage.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.